The clinical task is to restore enough bone volume in the correct three-dimensional position to permit prosthetically driven implant placement. Modern protocols select between guided bone regeneration, sinus floor elevation, and block grafting based on defect size, defect morphology, and anatomical location.

Biomaterials Overview

Bone grafts are classified by source. Autogenous bone, harvested from the patient, is osteogenic, osteoinductive, and osteoconductive and remains the historical benchmark. Allografts (human cadaveric) provide osteoinductive and osteoconductive properties. Xenografts, most commonly deproteinized bovine bone mineral, provide osteoconductive scaffolds with slow resorption. Alloplasts, synthetic materials including beta-tricalcium phosphate, hydroxyapatite, and bioactive glasses, are osteoconductive only. Jensen and Terheyden (2009), in a comprehensive systematic review, compared biomaterial classes and found that autogenous and xenogeneic materials achieve comparable implant survival in most localized augmentation contexts, with the chosen material often dictated by handling characteristics and defect morphology.

Guided Bone Regeneration (GBR)

GBR is the workhorse augmentation technique for localized horizontal defects, peri-implant dehiscences, and small to moderate vertical defects. The principle, formalized in the Buser-Dahlin-Schenk tradition, is the exclusion of soft tissue from the bone defect using a barrier membrane while a particulate grafting material maintains space and provides a scaffold for osteogenesis.

Membrane choice is the central technical decision. Resorbable collagen membranes are the modern default for routine horizontal defects, simplifying the protocol by avoiding a second surgery. Non-resorbable PTFE membranes, including titanium-reinforced designs, are indicated when greater space maintenance is required, particularly in vertical augmentation. Sanz-Sanchez et al. (2015), in a systematic review and meta-analysis, reported that lateral GBR achieves clinically meaningful crestal width gains, with implant survival in augmented sites comparable to native bone.

Sinus Floor Elevation

Maxillary sinus floor elevation, introduced by Tatum (1986) and refined into the transcrestal osteotome technique by Summers (1994), is one of the most studied procedures in implant dentistry. The lateral window approach is indicated when residual posterior maxillary bone height is below approximately 5 mm. The transcrestal approach is suited to cases with residual bone height of 5 mm or greater, often with simultaneous implant placement.

Pjetursson et al. (2008), in a landmark systematic review, reported implant survival rates exceeding 95 percent in sinus-augmented sites with follow-ups of 1 to 5 years. A 15-year retrospective study by Jamcoski et al. (2023) refined these numbers: survival was 96.0 percent without graft material and 99.6 percent with biomaterial; by graft type, survival was 92 percent for autogenous, 93.3 percent for allogeneic, 81 percent for alloplastic, and 95.6 percent for pure xenogeneic bone. Schneiderian membrane perforation, the most common intraoperative complication, can usually be managed with collagen patches and is not a strict contraindication to continuing the procedure.

Block Grafting

Block grafts are indicated when defect dimensions exceed what particulate GBR can predictably restore, particularly in vertical augmentation and large horizontal defects. Intraoral donor sites include the mandibular ramus and symphysis; extraoral sites include the iliac crest, used for severely atrophic full-arch cases. Autogenous blocks remain the historical gold standard for predictable volume gain. Aludden et al. (2017) systematically reviewed lateral ridge augmentation with bone block grafts and reported substantial crestal width gains, although resorption during healing must be accounted for in planning.

Allogeneic and xenogeneic bone blocks (notably deproteinized bovine bone blocks) have emerged as alternatives that avoid donor-site morbidity. A systematic review (PubMed 33930599) comparing autogenous block grafting with GBR reported implant survival of 97.9 percent for autogenous block (range 95.6 to 100 percent) and 98.5 percent for GBR (range 94.4 to 100 percent), confirming that both approaches deliver high implant survival when properly indicated.